Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06638801 · ClinicalTrials.gov registry record · NA
Brain Uptrain to Improve Learning and Development
A NA study of Term Infant and Late Preterm Infant, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 188
- Enrollment target
- 1
- Study location
NCT06638801: Recruiting NA study of Term Infant and Late Preterm Infant, sponsored by University of Alabama at Birmingham.
NCT06638801 is a NA study of Term Infant and Late Preterm Infant that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 188 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06638801, a NA study of Term Infant and Late Preterm Infant, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if an early literacy and developmental program in addition to shared reading can increase developmental test scores at 24 months of age. All caregivers of infants in this study will receive shared reading training. Half of the caregivers will be trained in an additional coach-led caregiver-implemented early literacy and numeracy program. Information related to infant development will be collected from parent surveys, medical records, and questionnaires and assessments.
Primary Outcome
The total Ages and Stages Questionnaires 3rd Edition score at 24 months
Conditions Studied
Interventions
- BEHAVIORAL Coach-led caregiver-implemented early literacy and developmental programming
- BEHAVIORAL Reach Out and Read Training
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2026-02-18 |
| Est. Completion | 2031-06-18 |
| Phase | NA |
What NCT06638801 shows while recruiting
NCT06638801 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Term Infant appearing as the primary indexed condition, and to 2 interventions - of which Coach-led caregiver-implemented early literacy and developmental programming is the first listed.
NCT06638801 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06638801 about?
NCT06638801 is a clinical study titled "Brain Uptrain to Improve Learning and Development". The purpose of this study is to see if an early literacy and developmental program in addition to shared reading can increase developmental test scores at 24 months of age. All caregivers of infants in this study will receive shared reading training. Half of the caregivers will be trained in an addi...
What is the current status of trial NCT06638801?
This trial is currently recruiting. It is a NA study. The enrollment target is 188 participants. The study started on 2026-02-18. Estimated completion is 2031-06-18.
What conditions does trial NCT06638801 study?
This clinical trial studies the following conditions: Term Infant, Late Preterm Infant.
What interventions are being tested in trial NCT06638801?
The interventions under investigation include: Coach-led caregiver-implemented early literacy and developmental programming (BEHAVIORAL), Reach Out and Read Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06638801?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06638801 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Term Infant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06638801's enrollment target sits among peer trials
188 576th of 2000 higher than 1,422 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI